Description: Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products. The Resource Efficiency segment provides high-performance materials and specialty additives, such as hydrogen peroxide, activated nickel catalysts, precious metal powder catalysts, oil and fat hydrogenation catalysts, amorphous polyalphaolefins, polybutadienes, polyester resins, thermoplastic and reactive methacrylate resins, organically modified silicones, isophorone chemistry, PEEK, polyamide 12, oil additives, organosilanes, chlorosilanes, fumed silicas, fumed metal oxides, precipitated silicas, and matting agents for the automotive, paints, coatings, adhesives, construction, and various other sectors. The Performance Materials segment produces polymer materials and intermediates, including butene-1, DINP, isononanol, cyanuric chloride, alcoholates, and methacrylate monomers and polymers for rubber, plastics, and agriculture industries. The Services segment provides site management, utilities and waste management, technical, process technology, engineering, and logistics services. The company is headquartered in Essen, Germany. Evonik Industries AG is a subsidiary of RAG-Stiftung.
Home Page: corporate.evonik.com
Rellinghauser Strasse 1-11
Essen,
45128
Germany
Phone:
49 201 177 3315
Officers
Name | Title |
---|---|
Mr. Christian Kullmann | CEO & Chairman of the Executive Board |
Dr. Harald Schwager | Deputy Chairman of the Executive Board |
Maike Schuh | CFO & Member of Executive Board |
Mr. Thomas Wessel | Chief Human Resources Officer, Labor Relations Director & Member of Executive Board |
Dr. Wilfried Ostendorf | Head of Production and Technology |
Mr. Tim Lange | Head of Investor Relations |
Mr. Thomas Mahlstedt | Vice President M&A, Corporate Legal & Compliance |
Christian Schmid | Head of Corporate Communications |
Dr. Stefan Mack | Head of the Methionine & Derivatives Product Line |
Mr. Matthias Ruch | Head of External Communications & Corporate Press Officer |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
GIC Sector: | Materials |
---|---|
GIC Group: | Materials |
GIC Industry: | Chemicals |
GIC Sub-Industry: | Specialty Chemicals |
Forward PE: | 19.3424 |
---|---|
Trailing PE: | 36.2745 |
Price-to-Book MRQ: | 0.9099 |
Price-to-Sales TTM: | 0.5811 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 32040 |